The record
Written from the 1 report below. Nothing here is unsourced.
- Three organisations — Sankalp India Foundation, DKMS, and Cure2Children — have completed 1,000 stem cell transplants for children with thalassemia in India, marking the milestone on September 4.
- Thalassemia patients typically need lifelong blood transfusions, which can cause serious iron overload affecting organs like the heart and liver.
- A family donor who fully matches on HLA can offer a cure, as in the case of 17-year-old Muhammad Shaheem from Karnataka, whose 7-year-old sister was his donor.
- The transplants are risky and costly, ranging from ₹12 lakh to ₹40 lakh, though DKMS has covered costs for more than 820 of the children treated.
What to watch next
- Whether more transplant centres are expanded, given Sankalp runs paediatric bone marrow transplant centres in Bengaluru and Ahmedabad and day-care centres serving over 3,000 children.
- Efforts to keep transplant costs affordable, since treatment in India ranges from ₹12 lakh to ₹40 lakh.
- Continued donor matching within families, as full HLA-matched sibling donors like Shaheem's sister remain key to enabling transplants.
Who said what2
Only words found exactly in the article are shown, attributed and linked to the line they came from.
Zareena
1 quote · 1 outlet
“I continue to undergo treatment and regular blood transfusions. Though it was a difficult decision to make in my son’s case, it has ultimately given my son a second chance for better life without being troubled much by the disease.”
In the article
…After extensive preparation and counselling at the Sankalp-Bhagwan Mahavir Jain Hospital in Bengaluru, his family decided to proceed with the transplant. Their mother, Zareena, who lives with thalassemia major, said, “ I continue to undergo treatment and regular blood transfusions. Though it was a difficult decision to make in my son’s case, it has ultimately given my son a second chance for better life without being troubled much by the disease. ” Mr. Shaheem is among 1,000 children who have undergone paediatric stem cell transplants with help from Sankalp India Foundation, DKMS, and Cure2Children. The procedure is both risky and expensive, and the treatment…
Rajat Kumar Agarwal
1 quote · 1 outlet
“For us, these 1,000 transplants are 1,000 beginnings and proof that cure can be made accessible when organisations combine their strengths with a shared purpose. It shows how centres in resource-constrained settings can still achieve success in medicine and internationally recognised quality while keeping transplantation affordable and accessible.”
In the article
…to more than 3,000 children through 30 thalassemia day-care centres and operates paediatric bone marrow transplant centres in Bengaluru and Ahmedabad. Rajat Kumar Agarwal, president of Sankalp India Foundation, said, “ For us, these 1,000 transplants are 1,000 beginnings and proof that cure can be made accessible when organisations combine their strengths with a shared purpose. It shows how centres in resource-constrained settings can still achieve success in medicine and internationally recognised quality while keeping transplantation affordable and accessible. ” Published - September 04, 2026 09:48 pm IST…
Coverage1
All filed from India
Named India · Muhammad Shaheem · Sankalp-Bhagwan Mahavir Jain Hospital · Cure2Children Foundation · DKMS · Rajat Kumar Agarwal · Sankalp India Foundation · Zara · Zareena
The 1 report is listed beside the record.
Ask this story
Answers cite the reports above, or say they can't.
